Ismene Petrakis, MD
Enriched profileProfessor of Psychiatry, Yale University School of Medicine; Chief of Psychiatry, VA Connecticut Healthcare System · Yale University School of Medicine
Ismene Petrakis is Professor of Psychiatry, Yale University School of Medicine; Chief of Psychiatry, VA Connecticut Healthcare System at Yale University School of Medicine. OpenAlex indexes 249 publications with 9,127 citations (h-index 53); ClinicalTrials.gov lists 19 registered studies with this person as an investigator.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Ismene Petrakis, MD, is Professor of Psychiatry, Yale University School of Medicine. The public record shows 249 publications with 9,127 citations (h-index 53), centered on Substance Abuse Treatment and Outcomes, Neurotransmitter Receptor Influence on Behavior, Posttraumatic Stress Disorder Research. It also documents an investigator role on 19 registered clinical trials, industry payments reported by 1 companies, 11 NIH-funded awards (1995–2026).
- Most recent indexed publication: 2026 · The American journal on addictions
- Top research focus: Substance Abuse Treatment and Outcomes
- 19 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 139.
Clinical & industry
trials, payments and federal fundingContact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
950 Campbell Ave, 116-A, West Haven, CT 06516
Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 19 registered studies on ClinicalTrials.gov. The most recent:
- Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
- Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
Sponsor: VA Office of Research and Development
Industry payments
Updated 18 Oct 2026
1 company reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20254 payments$11,985openpaymentsdata.cms.gov ↗
NIH funding
Updated 18 Oct 2026
11 NIH research awards on record, funded 1995–2026 per NIH RePORTER. The latest:
- A Translational Human Laboratory Model to Elucidate Mechanisms of Alcohol's Impact on Pain in Co-Occurring Alcohol Use Disorder and Chronic Pain
Yale University
FY2026$578,234R01AA032917 - Research Training Fellowship in Substance use and Addiction (RTFSA)
Yale University
FY2026$301,050T32DA007238
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Proceedings of the 36th Annual Meeting and Scientific Symposium.
The American journal on addictions
Editorial2026 - Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo-controlled crossover laboratory study.
The American journal on addictions
Clinical Trial2025 - Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine.
The American journal on addictions
Clinical Trial2024 - Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans.
Addiction science & clinical practice
Article2022
Most-cited works
by citation count (OpenAlex)- 01Sex differences in stress-related alcohol useArticle414 citations2019
- 02
- 03
- 04Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking SmokersArticle298 citations2009
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/ismene-petrakis-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
medicine.yale.edu/profile/ismene_petrakis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Mentions by others
where others cite or feature them- Other
aaap.org/new-editor-in-chief-selected-for-the-american-journal-on-addictions
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aaap.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Editorial & leadership roles
journal and society appointments- Editor-in-Chief
The American Journal on Addictions
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aaap.org ↗ - Director
Addiction Psychiatry Residency, Yale University School of Medicine (ACGME-accredited)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Member
Accreditation Council for Graduate Medical Education
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aaap.org ↗ - Member
American Academy of Addiction Psychiatry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aaap.org ↗ - Member
Research Society on Alcoholism
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aaap.org ↗ - Member
American Board of Addiction Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aaap.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
- Outstanding Achievement and Service Award
American Academy of Addiction Psychiatry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →education.aaap.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- VA Connecticut Healthcare System
Chief of Psychiatry
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Scott Woods, MD
Yale University School of Medicine
Anne Chiang, MD
Yale University School of Medicine
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons